Last info update: December 2022
Kevin flanagan email & phone, associate director mspv compliance, pv agreements, training and qppv office at Intercept pharmaceuticals

Kevin Flanagan — Contact Information

Associate Director Mspv Compliance, Pv Agreements, Training And Qppv Office, Human_resources

Kevin Flanagan's Email, Phone & Whatsapp Number and other Contact Information

  • Emails Email k***com
    k***com
    f***com
    Open contact Available for registered users
  • Location Location New York, New York, United States
  • Skills Skills Pharmaceutical Industry · Pharmacovigilance · Clinical Trials · Clinical Development · Gcp · Data Management · Cro · Regulatory Requirements · Drug Safety · Sop · Ctms · Regulatory Affairs · Oncology · Governance · Strategy · 21 Cfr Part 11 · Regulatory Submissions · Management · Clinical Monitoring · Biopharmaceuticals · Clinical Research · Fda · Biotechnology · Therapeutic Areas · Standard Operating Procedure · E Discovery Consulting · Medical Writing · Compliance · Human Resources · Change Management · Infectious Diseases · Ich Gcp · Neurology · Computer System Validat

Kevin Flanaganis a Associate Director Mspv Compliance, Pv Agreements, Training And Qppv Office. Works at Intercept Pharmaceuticals(United States). Located in New York, New York, United States. Open Kevin Flanagan's email & phone: K***com. Skilled in Pharmaceutical Industry · Pharmacovigilance · Clinical Trials · Clinical Development · Gcp · Data Management · Cro · Regulatory Requirements · Drug Safety · Sop · Ctms · Regulatory Affairs · Oncology · Governance · Strategy · 21 Cfr Part 11 · Regulatory Submissions · Management · Clinical Monitoring · Biopharmaceuticals · Clinical Research · Fda · Biotechnology · Therapeutic Areas · Standard Operating Procedure · E Discovery Consulting · Medical Writing · Compliance · Human Resources · Change Management · Infectious Diseases · Ich Gcp · Neurology · Computer System Validat.

Experience of Kevin Flanagan

Kevin flanagan's Company Details

Intercept Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering and developing small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases. It offers INT-747, a FXR modulating agent that tre Read more ats patients with chronic autoimmune liver diseases. The company's drug development programs also focus on modulating bile acid receptors, and amelioration of metabolic and hepatic functions in chronic liver diseases. Intercept Pharmaceuticals, Inc. was founded in 2002 and is based in New York, New York.

  • Company Emails [email protected]
  • Company Phone 646-747-1000
  • Company Website interceptpharma.com
  • Company Location new york, new york, united states
  • Industry pharmaceuticals
  • Company Size 501-1000
  • Found Year 2022
Click to load map
Colleagues
Similar employees

Frequently Asked Questions

Directories